Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using vibration and low‑intensity electrical pulses to improve arm proprioception after stroke

Official title: Investigating the Impact of Afferent Stimulation on Proprioceptive Function in Post-Stroke Rehabilitation

Run by Universidad Rey Juan Carlos · NCT07073989 · Data updated 2026-11-12

This project tests whether a wearable device that delivers gentle vibrations and low‑intensity electrical pulses can improve arm position and movement sense in people with chronic stroke, with healthy volunteers included for comparison.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversidad Rey Juan Carlos
Academic / other
Locations1 site (Móstoles, Madrid)
StatusRecruiting
StartedJune 17, 2025
Main results expectedSeptember 2025
Study endsSeptember 2025
Registry record updatedJuly 20, 2025
Trial IDNCT07073989 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are adults with chronic ischemic or hemorrhagic stroke causing hemiparesis and mild‑to‑moderate upper‑limb impairment (Fugl‑Meyer upper‑limb 35–53) with MMSE >24 and the cognitive ability to follow instructions, and healthy volunteers without upper‑limb or neurological conditions for comparison.

Probably not a fit

Patients with severe upper‑limb impairment, recent upper‑limb surgery, significant cognitive impairment (MMSE ≤24), acute stroke, or other unstable medical/orthopedic conditions are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study applies afferent stimulation—mechanical vibrations combined with low‑intensity electrical currents—to deliver enhanced proprioceptive feedback to the upper limb. Sessions will compare responses in people with chronic stroke and in healthy volunteers to characterize device effects and baseline sensory function. Eligible stroke participants have chronic ischemic or hemorrhagic stroke with mild‑to‑moderate upper‑limb impairment and sufficient cognition (MMSE >24). Outcome measures will include standardized upper‑limb motor and sensory scores such as the Fugl‑Meyer upper‑limb sections and functional performance tests conducted at Universidad Rey Juan Carlos.

Why it matters

Potential benefit: If successful, the device could improve patients' sense of arm position and movement and potentially speed or enhance recovery of upper‑limb function.

How similar studies have gone: Prior small studies using sensory stimulation, vibration, or low‑intensity electrical inputs have shown promising but mixed improvements in proprioception and motor control, so the approach is plausible but not yet definitively proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* For healthy subjects:

  1. No neurological or orthopedic conditions affecting upper limb movement.
  2. No surgical interventions on the upper limbs within the past 6 months.
  3. General physical condition adequate to perform the session.
  4. Cognitive abilities sufficient to understand and carry out the experimental procedure.
* For stroke survivors:

  1. Ischemic or hemorrhagic stroke resulting in motor impairments in the upper limb.
  2. Chronic stroke condition.
  3. Subjects with sufficient cognitive abilities to follow instructions and actively participate in the therapy.
  4. Mini-Mental State Examination (MMSE) score \> 24.
  5. Subjects presenting hemiparesis and mild-to-moderate impairment in the upper limb (score on the Fugl-Meyer Motor Assessment for the upper limb, sections A-D, between 35 and 53 points). The maximum score on the FM scale is 66, with the following severity classifications:
* 0-15: severe impairment
* 16-34: moderate-to-severe impairment
* 35-53: mild-to-moderate impairment
* 54-66: mild impairment 6. Subjects presenting upper limb hypertonia with a score below 3 on the Modified Ashworth Scale.

  7\. Subjects who have signed the informed consent document to voluntarily participate in the experiments.

Exclusion Criteria:

1. Acute musculoskeletal disorders.
2. Peripheral vascular diseases.
3. Acute cardiopulmonary conditions.
4. Acute neurological disorders.
5. Restricted mobility of upper limb joints due to any cause.
6. Pain as a cause of impaired upper limb mobility.

Where it's running

  • Universidad Rey Juan Carlos
    Móstoles, Madrid, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.